Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
TFEB Links Autophagy to Lysosomal Biogenesis
2011 StandoutScience
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Single molecules of the bacterial actin MreB undergo directed treadmilling motion in Caulobacter crescentus
2006 StandoutNobel
WIP is essential for lytic granule polarization and NK cell cytotoxicity
2008
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
The MEK1 Scaffolding Protein MP1 Regulates Cell Spreading by Integrating PAK1 and Rho Signals
2005
Polycomb Group Protein Enhancer of Zeste 2 Is an Oncogene That Promotes the Neoplastic Transformation of a Benign Prostatic Epithelial Cell Line
2009
Antitumor Effects and Biomarkers of Activity of AZD0530, a Src Inhibitor, in Pancreatic Cancer
2009
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
2015
Gastric cancer
2016 Standout
Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers
2006
Depletion of CD4+CD25+ human regulatory T cells in vivo: Kinetics of Treg depletion and alterations in immune functions in vivo and in vitro
2007
MEK partner 1 (MP1): Regulation of oligomerization in MAP kinase signaling
2004
‘Ins and outs’ of seven-transmembrane receptor signalling to ERK
2004
Src kinase contributes to the metastatic spread of carcinoma cells
2002
Pancreatic cancer
2004 Standout
Single-Molecule Discrimination of Discrete Perisynaptic and Distributed Sites of Actin Filament Assembly within Dendritic Spines
2010 StandoutNobel
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
2005 Standout
A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors
2013 Standout
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment—Report of 33 Cases
2009
Imaging in the era of molecular oncology
2008 StandoutNature
The Human T Cell Response to Melanoma Antigens
2006
Control of motile and invasive cell phenotypes by focal adhesion kinase
2004
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
2015 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
FOXP3 and scurfy: how it all began
2014 StandoutNobel
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
2009 StandoutNobel
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Use of tumour-responsive T cells as cancer treatment
2009
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Fibronectin, integrins, and growth control
2001
cAMP/PKA signalling reinforces the LATS–YAP pathway to fully suppress YAP in response to actin cytoskeletal changes
2013
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Minority Issues in Prostate Disease
2005
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Phase transitions in the assembly of multivalent signalling proteins
2012 StandoutNature
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Cancer immunotherapy comes of age
2011 StandoutNature
MicroRNA signatures in human cancers
2006 Standout
Pancreatic Cancer
2010 Standout
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
2007 StandoutNobel
Regulation of cytoskeletal dynamics by actin-monomer-binding proteins
2004
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Immunity to Melanoma Antigens: From Self‐Tolerance to Immunotherapy
2006
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
2004 Standout
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
HS1 Functions as an Essential Actin-Regulatory Adaptor Protein at the Immune Synapse
2006
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Integrins
2002 Standout
Physical Mechanisms of Signal Integration by WASP Family Proteins
2010
Molecular biology of gastric cancer*
2002
The Polycomb complex PRC2 and its mark in life
2011 StandoutNature
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Pancreatic cancer
2011 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic Protein 1 in lymphopoiesis and innate immunity
2008 StandoutNobel
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo
2006
CrkII regulates focal adhesion kinase activation by making a complex with Crk-associated substrate, p130 Cas
2004
Focal adhesion kinase: the first ten years
2003
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
2006 StandoutNature
Activity-Dependent Redistribution and Essential Role of Cortactin in Dendritic Spine Morphogenesis
2003
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
SKI-606, a Src/Abl Inhibitor withIn vivoActivity in Colon Tumor Xenograft Models
2005
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Induction of CD8+T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
2010
Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
2002
Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
2009
Conditional Deletion of Focal Adhesion Kinase Leads to Defects in Ventricular Septation and Outflow Tract Alignment
2007 StandoutNobel
Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting
2007
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Effectiveness of Management Strategies for Renal Artery Stenosis: A Systematic Review
2006
Cortactin promotes exosome secretion by controlling branched actin dynamics
2016
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Eric A. Bissonette being referenced
Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma
2001
Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells
2001
Cortactin Interacts with WIP in Regulating Arp2/3 Activation and Membrane Protrusion
2003
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patients
2005
Activated 3′,5′-Cyclic AMP-dependent Protein Kinase Is Sufficient to Induce Neuroendocrine-like Differentiation of the LNCaP Prostate Tumor Cell Line
2000
Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer
2000
Allelic Imbalance of 8p Indicates Poor Survival in Gastric Cancer
2004
Assessment of the Toxicities of Systemic Low-Dose Interleukin-2 Administered in Conjunction with a Melanoma Peptide Vaccine
2004
Safety of CO2- and Gadodiamide-Enhanced Angiography for the Evaluation and Percutaneous Treatment of Renal Artery Stenosis in Patients with Chronic Renal Insufficiency
2001
MAGE-A1-, MAGE-A10-, and gp100-Derived Peptides Are Immunogenic When Combined with Granulocyte-Macrophage Colony-Stimulating Factor and Montanide ISA-51 Adjuvant and Administered as Part of a Multipeptide Vaccine for Melanoma
2005
PROSTATE SPECIFIC ANTIGEN KINETICS AT TUMOR RECURRENCE AFTER RADICAL PROSTATECTOMY DO NOT SUGGEST A WORSE DISEASE PROGNOSIS IN BLACK MEN
2001
Immunologic and Clinical Outcomes of Vaccination With a Multiepitope Melanoma Peptide Vaccine Plus Low-Dose Interleukin-2 Administered Either Concurrently or on a Delayed Schedule
2004
Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa
2001
Modular construction of a signaling scaffold: MORG1 interacts with components of the ERK cascade and links ERK signaling to specific agonists
2004
Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells.
2003